Climatic Chamber Configurator
Discover the Climatic Chamber Configurator
Our guide to choosing the climate chamber best suited to your needs.

“Cold chain” is a term that gained a lot of popularity in a specific phase of the Covid-19, during the initial distribution of vaccines.
As often happens, with the passage of time and the return to normality, this word seems to have fallen into oblivion once again. But regardless of the news stories, the cold chain existed before, during, and after the pandemic and continues to play a crucial role in the logistics of many goods.
Today we are talking about the cold chain and its essential role in our society.
We call the cold chain the set of operations necessary to ensure the maintenance of optimal thermal conditions for heat-sensitive products during all phases of their production, storage, and distribution.
For example, during the pandemic ground transportation needed to be equipped to keep their containers at sufficiently low temperatures to preserve vaccines.
However, this process is essential to preserve the quality and safety of a wide range of products, including foods, drugs and other biological materials.
Let's take a closer look at how it works.
Discover the new series of Environmental Chambers for controlled climate testing.
Find out more.

Just like a real supply chain, the cold chain is based on a series of highly interconnected steps that aim to maintain products at specific temperatures, from the point of origin to the final consumer. These steps include:
The cold chain is essential in many sectors, including:
play a fundamental role in the cold chain .
We call ultra-low freezers those freezers capable of reaching and maintaining extremely low temperatures. How low?
There is no official threshold that distinguishes a freezer from an ultra-low temperature freezer. Conventionally, an ultra-low temperature freezer is one that can go below -40°C. However, most freezers stop at around -25°C.
Whilefreezers in the food sector are capable of maintaining and preserving food within the cold chain, when it comes to pharmaceuticals or biological samples, the situation is different.
For this reason, ultra-low freezers are essential in the pharmaceutical and research industries because the temperatures required to preserve the active ingredients of these products are extremely low.
Build your environment directly online, based on your specific needs.
Find out more.

FDM – Environment Makers is a company with over 70 years of experience in the field of climate simulation.
FDM ultra-low temperature freezers are equipped with advanced technologies for precise temperature control and ensure safe and efficient storage of sensitive products, making them ideal for the cold chain.
For further information, please do not hesitate to contact us.
Contact us for more information about this product.
Contact Us
Four standard ranges: Frozen (-25°C to -15°C) for frozen vaccines and plasma; Refrigerated (2°C to 8°C) for most vaccines and biologicals; Cool (8°C to 15°C) for some specific products; Controlled Chamber Temperature (CRT) (15°C to 25°C) for many stable drugs. For mRNA vaccines (Pfizer/Moderna) , Ultra-Low (-80°C to -60°C) is added
The standard protocol includes unloaded and loaded thermal mapping in a climatic chamber with extreme cycles (e.g., -20°C and +40°C for 72 hours), recording with at least 9 sensors (corners + center), hold time validation, and Time Out of Refrigeration (TOR) compliance. Passive containers (e.g., Pelican BioThermal) must guarantee 72–120 hours without intervention. Active containers (refrigerated containers) require full PQ qualification.
Static mapping ( ISPE Good Practice Guide) characterizes stationary chambers/containers with temperature distribution throughout the volume (uniformity < ±2°C). Dynamic mapping records temperature profiles during actual transport (shock door-opening, airport transit, tarmac sun exposure). For full GDP qualification, a worst-case summer route (e.g., Mumbai-Frankfurt, July) is required with data loggers calibrated every 5 minutes.
A Temperature Excursion Investigation: data logger collection, comparison with the vaccine's stability budget (each product has documented limitations, e.g., Pfizer mRNA tolerates 2-8°C for an additional 31 days), and batch release/reject decision. WHO publishes stability sheets for each prequalified vaccine. For non-vaccine drugs, the stability budget is based on ICH Q1A kinetics of Arrhand defined by the marketing authorization holder.
Do you need to pass a regulatory test or are you looking for a chamber designed to your test protocol? Tell us your needs: the FDM technical team will respond to you, without intermediaries.